68N-20602-18654

2 vaccinations 6 coded responses 6 check-ins 6 free-text entries 6 call cases

Sex: Female
Age at first dose: 51-55
ZIP prefix: 333 / FL
Registered: 2021-07-05

Relationship: Self
Race: Black or African American
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2342003 (opens in a new window)	high	8 / 11	5	0 of 4 VAERS symptoms	same dose (2)	FL matches	2021-06-28 / 2021-06-28 / 2022-06-29 received the same day as the last call	case 811595

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-06-07
Dose 1 — Pfizer-BioNTech
2021-06-28
Dose 2 — Pfizer-BioNTech
2021-07-05
Registered in v-safe
2021-07-05
Survey response — day 7, dose 2
MedDRA: Dizziness, Dyspnoea, Pharyngeal swelling, Pruritus, Swollen tongue, Throat irritation, Tonsillar hypertrophy — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Difficulty breathing with and without exertion. Swelling and itching in throat and tongue. Dizziness, burning throat, swollen tonsils

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-05
Report sent to call center — day 7, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-08
Call 2 — Left Voicemail
2021-07-12
Survey response — day 14, dose 2
MedDRA: Anaphylactic reaction, Asthenia, Dizziness, Dust allergy, Dyspnoea, Headache, Hypoaesthesia, Pharyngeal swelling, Pre-existing disease, Vision blurred, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Extreme anaphylaxic sensitivity to foods, dust, medications, with shortness of breath, dizziness, vomiting. Blurred visions, extreme weakness, headache, swelling in throat. As of today numbness in various body parts.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-12
Report sent to call center — day 14, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-20
Survey response — day 21, dose 2
MedDRA: Anaphylactic reaction, Asthenia, Dehydration, Dizziness, Headache, Pharyngeal swelling, Vision blurred, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Anaphylactic response to all foods eaten with vomiting.throat swelling, Dehydration, dizzy, severe headaches, extreme weakness with and without exertion, blurred vision.,

MedDRA releases: 2024-11 · check-in free text available
2021-07-20
Report sent to call center — day 21, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-21
Call 2 — Left Voicemail
2021-07-26
Survey response — day 28, dose 2
MedDRA: Dyspnoea, Eating disorder, Emergency care, Fatigue, Food allergy, Gait disturbance, Headache, Hospitalisation, Migraine, Paraesthesia, Sitting disability, Visual impairment, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: Difficulty walking, sitting, eating without exaustion, shortness of breath, extreme fatigue. Difficulty seeing, increased. Headaches and migraines. Tingling and needles in fingers and toes. Continued vomiting and various allergic reactions to foods, · Healthcare visit (other): Referred to specialist after emergency and Hospitalizations

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-07-26
Report sent to call center — day 28, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-08-03
Survey response — day 35, dose 2
MedDRA: Chest pain, Constipation, Dysarthria, Dysphemia, Dyspnoea, Headache, Speech disorder, Urine output decreased, Vision blurred — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: headaches, blurred vision worsened, studdering, slurred speach, unable to verbalize words, shortness of breath, chest pain, decreased urination, severe constipation.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-03
Report sent to call center — day 35, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-08-03
Call 2 — Left Voicemail
2022-01-19
Call successful
Other
2022-06-26
Call 1 — Left Voicemail
2022-06-28
Survey response — 12 months, dose 2
MedDRA: Abdominal pain, Disability, Hospitalisation, Hypersensitivity, Photophobia, Reaction to preservatives, Seizure, Transient ischaemic attack, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Hosp. Adm. 6/11/22 for a TIA had a severe allergic reaction to flaxseed oil with ascorbic citrate acid and other preservatives. increased sensitivity to sunlight, computer light ect. Vomiting, convulsions, adominal pain ect. Disability as of 6/17/22.

MedDRA releases: 2024-11 · check-in free text available
2022-06-28
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-06-29
Call 1 — Left Voicemail
2022-06-29
Call 1 — Left Voicemail
2022-06-29
Call 1 — Left Voicemail
2022-06-29
Call 1 — Left Voicemail
2022-06-29
Call 1 — Left Voicemail
2022-06-29
Call successful
Completed over the phone

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-06-07	Pfizer-BioNTech	No
2	2021-06-28	Pfizer-BioNTech	No

Call center

6 call center cases

6 successful

VAERS report filed, before or during a call: 4

2 waits over 3 months for a first call

See the call center timeline

Free text

Release 9 — day 7, dose 2

2021-07-05

Systemic reaction (other): Difficulty breathing with and without exertion. Swelling and itching in throat and tongue. Dizziness, burning throat, swollen tonsils

Release 9 — day 14, dose 2

2021-07-12

Symptoms: Extreme anaphylaxic sensitivity to foods, dust, medications, with shortness of breath, dizziness, vomiting. Blurred visions, extreme weakness, headache, swelling in throat. As of today numbness in various body parts.

Release 9 — day 21, dose 2

2021-07-20

Symptoms: Anaphylactic response to all foods eaten with vomiting.throat swelling, Dehydration, dizzy, severe headaches, extreme weakness with and without exertion, blurred vision.,

Release 9 — day 28, dose 2

2021-07-26

Symptoms: Difficulty walking, sitting, eating without exaustion, shortness of breath, extreme fatigue. Difficulty seeing, increased. Headaches and migraines. Tingling and needles in fingers and toes. Continued vomiting and various allergic reactions to foods, cut off by CDC

Healthcare visit (other): Referred to specialist after emergency and Hospitalizations

Release 9 — day 35, dose 2

2021-08-03

Symptoms: headaches, blurred vision worsened, studdering, slurred speach, unable to verbalize words, shortness of breath, chest pain, decreased urination, severe constipation.

Release 12 — 12 months, dose 2

2022-06-28

Symptoms: Hosp. Adm. 6/11/22 for a TIA had a severe allergic reaction to flaxseed oil with ascorbic citrate acid and other preservatives. increased sensitivity to sunlight, computer light ect. Vomiting, convulsions, adominal pain ect. Disability as of 6/17/22. cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Emergency care	✓	·	✓
HCVO	Hospitalisation	✓	·	✓
SD	Abdominal pain	·	·	✓
SD	Anaphylactic reaction	○	✓	✓
SD	Asthenia	✓	✓	✓
SD	Chest pain	✓	·	✓
SD	Constipation	✓	·	✓
SD	Dehydration	·	·	✓
SD	Disability	·	·	✓
SD	Dizziness	✓	✓	✓
SD	Dust allergy	○	✓	○
SD	Dysarthria	✓	·	✓
SD	Dysphemia	✓	·	✓
SD	Dyspnoea	✓	✓	✓
SD	Eating disorder	✓	·	✓
SD	Fatigue	✓	·	✓
SD	Food allergy	✓	·	✓
SD	Gait disturbance	✓	·	✓
SD	Headache	✓	✓	✓
SD	Hospitalisation	·	·	✓
SD	Hypersensitivity	·	·	✓
SD	Hypoaesthesia	✓	✓	✓
SD	Migraine	✓	·	✓
SD	Paraesthesia	✓	·	✓
SD	Pharyngeal swelling	✓	✓	✓
SD	Photophobia	·	·	✓
SD	Pre-existing disease	✓	·	✓
SD	Reaction to preservatives	·	·	✓
SD	Seizure	·	·	✓
SD	Sitting disability	✓	·	✓
SD	Speech disorder	✓	·	✓
SD	Transient ischaemic attack	·	·	✓
SD	Urine output decreased	✓	·	✓
SD	Vision blurred	✓	✓	✓
SD	Visual impairment	✓	·	✓
SD	Vomiting	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Pharyngeal swelling	✓	✓	✓
SRO	Pruritus	✓	✓	✓
SRO	Swollen tongue	✓	✓	✓
SRO	Throat irritation	✓	✓	✓
SRO	Tonsillar hypertrophy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release